Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD

European Neuropsychopharmacology

Volumn 23, Issue 6, 2013, Pages 479-491

  Lesch, K P ^a,b   Merker, S ^a   Reif, A ^a   Novak, M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Attention deficit hyperactivity disorder; Cell adhesion; FLRT3; Frontostriatal; Glutamate receptor; GRM5; Latrophilin; Latrotoxin; LPHN3; MACROD2; Neuronal connectivity; ODZ3; Synaptic plasticity

Indexed keywords

FIBRONECTIN LEUCINE RICH REPEAT TRANSMEMBRANE PROTEIN 3; GLUTAMIC ACID; LATROPHILIN 3; METABOTROPIC RECEPTOR 5; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NERVE CELL ADHESION MOLECULE; NEUROLIGIN 1; NEURONAL NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHOLIPASE C; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ALTERNATIVE RNA SPLICING; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; CELL ADHESION; CELL MIGRATION; DENDRITIC SPINE; DORSAL ATTENTION NETWORK; EXECUTIVE FUNCTION; EXOCYTOSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HAPLOTYPE; HERITABILITY; HUMAN; INTRACELLULAR SIGNALING; LATRODECTUS MACTANS; MEMORY CONSOLIDATION; MICROSATELLITE MARKER; MONOAMINERGIC SYSTEM; MOTIVATION; NERVE CELL PLASTICITY; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; POSTSYNAPTIC DENSITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; SUBSTANTIA NIGRA PARS COMPACTA; SYNAPTIC EFFICACY; SYNAPTOGENESIS; VENTRAL TEGMENTUM; WORKING MEMORY;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CORPUS STRIATUM; GENETIC VARIATION; GLUTAMIC ACID; HUMANS; LEARNING; LIGANDS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NEURONS; RECEPTOR, METABOTROPIC GLUTAMATE 5; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84877926095     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.07.013     Document Type: Article

References (140)

1. Anney R., Klei L., Pinto D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., Sykes N., Pagnamenta A.T., et al. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 2010, 19:4072-4082.
2. Arcos-Burgos M., Jain M., Acosta M.T., Shively S., Stanescu H., Wallis D., Domene S., Velez J.I., Karkera J.D., Balog J., et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry 2010, 15:1053-1066.
3. Auerbach B.D., Osterweil E.K., Bear M.F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011, 480:63-68.
4. Augustin I., Korte S., Rickmann M., Kretzschmar H.A., Sudhof T.C., Herms J.W., Brose N. The cerebellum-specific Munc13 isoform Munc13-3 regulates cerebellar synaptic transmission and motor learning in mice. J. Neurosci. 2001, 21:10-17.
5. Beaulieu J.-M., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J. Biol. Chem. 2006, 281:32072-32080.
6. Benson D.L., Schnapp L.M., Shapiro L., Huntley G.W. Making memories stick: cell-adhesion molecules in synaptic plasticity. Trends Cell Biol. 2000, 10:473-482.
7. Bockaert J., Perroy J., Becamel C., Marin P., Fagni L. GPCR interacting proteins (GIPs) in the nervous system: roles in physiology and pathologies. Annu. Rev. Pharmacol. Toxicol. 2010, 50:89-109.
8. Bottcher R.T., Pollet N., Delius H., Niehrs C. The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling. Nat. Cell Biol. 2004, 6:38-44.
9. Boucard A.A., Ko J., Sudhof T.C. High affinity neurexin binding to cell adhesion G-protein-coupled receptor CIRL1/latrophilin-1 produces an intercellular adhesion complex. J. Biol. Chem. 2012, 287:9399-9413.
10. Bush G. Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol. Psychiatry 2011, 69:1160-1167.
11. Cardinal R.N., Parkinson J.A., Hall J., Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci. Biobehav. Rev. 2002, 26:321-352.
12. Carmona S., Proal E., Hoekzema E.A., Gispert J.-D., Picado M., Moreno I., Soliva J.C., Bielsa A., Rovira M., Hilferty J., et al. Ventro-striatal reductions underpin symptoms of hyperactivity and impulsivity in attention-deficit/hyperactivity disorder. Biol. Psychiatry 2009, 66:972-977.
13. Caron M.G., Wightman R.M. To learn, you must pay attention. Molecular insights into teachers' wisdom. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7267-7268.
14. Carrey N., MacMaster F.P., Fogel J., Sparkes S., Waschbusch D., Sullivan S., Schmidt M. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clin. Neuropharmacol. 2003, 26:218-221.
15. Choudhry, Z., Sengupta, S.M., Grizenko, N., Fortier, M.E., Thakur, G.A., Bellingham, J., and Joober, R. (2012). LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy. J. Child Psychol. Psychiatry.
16. Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 1999, 274:27467-27473.
17. Cleva R.M., Olive M.F. Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders. Molecules 2011, 16:2097-2106.
18. Conn P.J., Christopoulos A., Lindsley C.W. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat. Rev. Drug Discov. 2009, 8:41-54.
19. Cubillo A., Halari R., Smith A., Taylor E., Rubia K. A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex 2012, 48:194-215.
20. Davies G., Tenesa A., Payton A., Yang J., Harris S.E., Liewald D., Ke X., Le Hellard S., Christoforou A., Luciano M., et al. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol. Psychiatry 2011, 16:996-1005.
21. 2+. EMBO J. 1998, 17:3909-3920.
22. de Zeeuw, P., Mandl, R.C., Hulshoff Pol, H.E., van Engeland, H., and Durston, S. (2011). Decreased frontostriatal microstructural organization in attention deficit/hyperactivity disorder. Hum. Brain Mapp.
23. Devon R.S., Anderson S., Teague P.W., Muir W.J., Murray V., Pelosi A.J., Blackwood D.H., Porteous D.J. The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol. Psychiatry 2001, 6:311-314.
24. Doron N.N., Ledoux J.E. Organization of projections to the lateral amygdala from auditory and visual areas of the thalamus in the rat. J. Comp. Neurol. 1999, 412:383-409.
25. Dorval K.M., Wigg K.G., Crosbie J., Tannock R., Kennedy J.L., Ickowicz A., Pathare T., Malone M., Schachar R., Barr C.L. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav. 2007, 6:444-452.
26. Drerup J.M., Hayashi K., Cui H., Mettlach G.L., Long M.A., Marvin M., Sun X., Goldberg M.S., Lutter M., Bibb J.A. Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35. Biol. Psychiatry 2010, 68:1163-1171.
27. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsater H., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 2007, 39:25-27.
28. Durand C.M., Perroy J., Loll F., Perrais D., Fagni L., Bourgeron T., Montcouquiol M., Sans N. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol. Psychiatry 2012, 17:71-84.
29. Elia J., Gai X., Xie H.M., Perin J.C., Geiger E., Glessner J.T., D'Arcy M., deBerardinis R., Frackelton E., Kim C., et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol. Psychiatry 2010, 15:637-646.
30. Elia J., Glessner J.T., Wang K., Takahashi N., Shtir C.J., Hadley D., Sleiman P.M.A., Zhang H., Kim C.E., Robison R., et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat. Genet. 2012, 44:78-84.
31. Fagni L., Bertaso F., Perroy J., Ango F. Unexpected roles of scaffolding proteins in receptor patho-physiological functions. J. Integr. Neurosci. 2008, 7:211-224.
32. Faraone S.V., Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr. Clin. North Am. 2010, 33:159-180.
33. Fernandino, E., 1621. Centum historiae seu observationes (Venice).
34. Franke, B., Faraone, S.V., Asherson, P., Buitelaar, J., Bau, C.H., Ramos Quiroga, J.A., Mick, E., Grevet, E.H., Johansson, S., Haavik, J., et al.,2011. The genetics of attention deficit/ hyperactivity disorder in adults, a review.Mol.Psychiatry. http://dx.doi.org/doi: 10.1038/mp.2011.138. [Epub ahead of print] PMID: 22105624 [PubMed - as supplied by publisher.
35. Franke B., Vasquez A.A., Johansson S., Hoogman M., Romanos J., Boreatti-Hummer A., Heine M., Jacob C.P., Lesch K.P., Casas M., et al. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology 2010, 35:656-664.
36. Gainetdinov R.R., Mohn A.R., Bohn L.M., Caron M.G. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:11047-11054.
37. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397-401.
38. Geissler J., Lesch K.P. A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms. Expert Rev. Neurother. 2011, 11:1467-1484.
39. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-612.
40. Grabrucker A.M., Schmeisser M.J., Schoen M., Boeckers T.M. Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol. 2011, 21:594-603.
41. Grishin E.V. Black widow spider toxins: the present and the future. Toxicon 1998, 36:1693-1701.
42. Gubellini P., Saulle E., Centonze D., Costa C., Tropepi D., Bernardi G., Conquet F., Calabresi P. Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. Neuropharmacology 2003, 44:8-16.
43. Halberstadt A.L., Lehmann-Masten V.D., Geyer M.A., Powell S.B. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacology (Berl) 2011, 215:81-92.
44. Hoogman M., Aarts E., Zwiers M., Slaats-Willemse D., Naber M., Onnink M., Cools R., Kan C., Buitelaar J., Franke B. Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects. Am. J. Psychiatry 2011, 168:1099-1106.
45. Ichtchenko K., Khvotchev M., Kiyatkin N., Simpson L., Sugita S., Sudhof T.C. Alpha-latrotoxin action probed with recombinant toxin: receptors recruit alpha-latrotoxin but do not transduce an exocytotic signal. EMBO J. 1998, 17:6188-6199.
46. Jain, M., Velez, J.I., Acosta, M.T., Palacio, L.G., Balog. J., Roessler, E., Pineda, D., Londono, A.C., Palacio, L.G., Arbelaez, A., et al., 2012. A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. Mol. Psychiatry. 17 (7), 741-747, . http://dx.doi.org/10.1038/mp.2011.59.
47. Jia Z., Lu Y., Henderson J., Taverna F., Romano C., Abramow-Newerly W., Wojtowicz J.M., Roder J. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learn. Mem. 1998, 5:331-343.
48. Jia Z., Lu Y.M., Agopyan N., Roder J. Gene targeting reveals a role for the glutamate receptors mGluR5 and GluR2 in learning and memory. Physiol. Behav. 2001, 73:793-802.
49. Kachroo A., Orlando L.R., Grandy D.K., Chen J.-F., Young A.B., Schwarzschild M.A. Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J. Neurosci. Off. J. Soc. Neurosci. 2005, 25:10414-10419.
50. Karaulanov E., Bottcher R.T., Stannek P., Wu W., Rau M., Ogata S., Cho K.W., Niehrs C. Unc5B interacts with FLRT3 and Rnd1 to modulate cell adhesion in Xenopus embryos. PLoS One 2009, 4:e5742.
51. Kircher, A., 1641. Athanasius Kircher (1641) Magnes sive de arte magnetica, Rome.
52. Kirov G., Rujescu D., Ingason A., Collier D.A., O'Donovan M.C., Owen M.J. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr. Bull. 2009, 35:851-854.
53. Klein R. Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nat. Neurosci. 2009, 12:15-20.
54. Knafo, S., and Esteban, J.A. (2012). Common pathways for growth and for plasticity. Curr. Opin. Neurobiol.
55. Kopf, J., Schecklmann, M., Hahn, T., Dieler, A.C., Herrmann, M.J., Fallgatter, A.J., and Reif, A. (2011). NOS1 ex1f-VNTR polymorphism affects prefrontal oxygenation during response inhibition tasks. Hum. Brain Mapp.
56. Krapacher F.A., Mlewski E.C., Ferreras S., Pisano V., Paolorossi M., Hansen C., Paglini G. Mice lacking p35 display hyperactivity and paradoxical response to psychostimulants. J. Neurochem. 2010, 114:203-214.
57. Krasnoperov V., Lu Y., Buryanovsky L., Neubert T.A., Ichtchenko K., Petrenko A.G. Post-translational proteolytic processing of the calcium-independent receptor of alpha-latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. Role of the G protein-coupled receptor proteolysis site (GPS) motif. J. Biol. Chem. 2002, 277:46518-46526.
58. Kreienkamp H.J., Zitzer H., Gundelfinger E.D., Richter D., Bockers T.M. The calcium-independent receptor for alpha-latrotoxin from human and rodent brains interacts with members of the ProSAP/SSTRIP/Shank family of multidomain proteins. J. Biol. Chem. 2000, 275:32387-32390.
59. Lange, M., Norton, W.,Coolen, M., Chaminade, M., Merker, S., Proft, F., Schmitt, A., Vernier, P., Lesch, K.P., Bally-Cuif, L., 2012. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol. Psychiatry. http://dx.doi.org/doi:10.1038/mp.2012.29. [Epub ahead of print] PMID: 22508465 [PubMed - as supplied by publisher].
60. LeDoux J. The emotional brain, fear, and the amygdala. Cell. Mol. Neurobiol. 2003, 23:727-738.
61. Lesch K.P., Timmesfeld N., Renner T.J., Halperin R., Roser C., Nguyen T.T., Craig D.W., Romanos J., Heine M., Meyer J., et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J. Neural. Transm. 2008, 115:1573-1585.
62. Lionel A.C., Crosbie J., Barbosa N., Goodale T., Thiruvahindrapuram B., Rickaby J., Gazzellone M., Carson A.R., Howe J.L., Wang Z., et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci. Transl. Med. 2011, 3:95ra75.
63. Liu Q.R., Drgon T., Johnson C., Walther D., Hess J., Uhl G.R. Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2006, 141B:918-925.
64. Lovinger D.M. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 2010, 58:951-961.
65. Lüscher C., Huber K.M. Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 2010, 65:445-459.
66. MacMaster F.P., Carrey N., Sparkes S., Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol. Psychiatry 2003, 53:184-187.
67. Mao L., Yang L., Arora A., Choe E.S., Zhang G., Liu Z., Fibuch E.E., Wang J.Q. Role of protein phosphatase 2A in mGluR5-regulated MEK/ERK phosphorylation in neurons. J. Biol. Chem. 2005, 280:12602-12610.
68. Masuo Y., Ishido M., Morita M., Oka S. Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats. Neurosci. Lett. 2002, 335:124-128.
69. Mick E., Neale B., Middleton F.A., McGough J.J., Faraone S.V. Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B:1412-1418.
70. Miyamoto K., Nakanishi H., Moriguchi S., Fukuyama N., Eto K., Wakamiya J., Murao K., Arimura K., Osame M. Involvement of enhanced sensitivity of N-methyl-d-aspartate receptors in vulnerability of developing cortical neurons to methylmercury neurotoxicity. Brain Res. 2001, 901:252-258.
71. Moessner R., Marshall C.R., Sutcliffe J.S., Skaug J., Pinto D., Vincent J., Zwaigenbaum L., Fernandez B., Roberts W., Szatmari P., et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 2007, 81:1289-1297.
72. Molina-Holgado E., Dewar K.M., Grondin L., van Gelder N.M., Reader T.A. Amino acid levels and gamma-aminobutyric acid: A receptors in rat neostriatum, cortex, and thalamus after neonatal 6-hydroxydopamine lesion. J. Neurochem. 1993, 60:936-945.
73. Montague P.R., Hyman S.E., Cohen J.D. Computational roles for dopamine in behavioural control. Nature 2004, 431:760-767.
74. Moss J., Bolam J.P. A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J. Neurosci. 2008, 28:11221-11230.
75. Naisbitt S., Kim E., Tu J.C., Xiao B., Sala C., Valtschanoff J., Weinberg R.J., Worley P.F., Sheng M. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 1999, 23:569-582.
76. Napolitano F., Bonito-Oliva A., Federici M., Carta M., Errico F., Magara S., Martella G., Nisticò R., Centonze D., Pisani A., et al. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. J. Neurosci. Off. J. Soc. Neurosci. 2010, 30:11043-11056.
77. Neale B.M., Medland S., Ripke S., Anney R.J., Asherson P., Buitelaar J., Franke B., Gill M., Kent L., Holmans P., et al. Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 2010, 49:906-920.
78. Nishi A., Watanabe Y., Higashi H., Tanaka M., Nairn A.C., Greengard P. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1199-1204.
79. Norton W., Lange M., Bally-Cuif L., Lesch K.P. Zebrafish models of attention-deficit/hyperactivity disorder (ADHD). The Rights and Wrongs Of Zebrafish 2012, Cambridge University Press, Cambridge. A.V. Kalueff (Ed.).
80. Novak M., Halbout B., O'Connor E.C., Rodriguez Parkitna J., Su T., Chai M., Crombag H.S., Bilbao A., Spanagel R., Stephens D.N., et al. Incentive learning underlying cocaine-seeking requires mGluR5 receptors located on dopamine D1 receptor-expressing neurons. J. Neurosci. Off. J. Soc. Neurosci. 2010, 30:11973-11982.
81. O'Sullivan M.L., de Wit J., Savas J.N., Comoletti D., Otto-Hitt S., Yates J.R., Ghosh A. FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development. Neuron 2012, 73:903-910.
82. Olive M.F., Cleva R.M., Kalivas P.W., Malcolm R.J. Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol. Biochem. Behav. 2012, 100:801-810.
83. Pasterkamp R.J., Giger R.J. Semaphorin function in neural plasticity and disease. Curr. Opin. Neurobiol. 2009, 19:263-274.
84. Peca J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., Lascola C.D., Fu Z., Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
85. Perroy J., Raynaud F., Homburger V., Rousset M.C., Telley L., Bockaert J., Fagni L. Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors. J. Biol. Chem. 2008, 283:6799-6805.
86. Plessen K.J., Bansal R., Zhu H., Whiteman R., Amat J., Quackenbush G.A., Martin L., Durkin K., Blair C., Royal J., et al. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 2006, 63:795-807.
87. Podkletnova I., Raevsky V., Alho H. Reduction of GABAergic transmission and alterations in behavior after 6-OHDA treatment of rats. Brain Res. Dev. Brain Res. 1996, 94:197-204.
88. 2+ and is mediated by latrophilin, G proteins and phospholipase C. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 1999, 354:379-386.
89. Reif A., Herterich S., Strobel A., Ehlis A.C., Saur D., Jacob C.P., Wienker T., Topner T., Fritzen S., Walter U., et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol. Psychiatry 2006, 11:286-300.
90. Reif A., Jacob C.P., Rujescu D., Herterich S., Lang S., Gutknecht L., Baehne C.G., Strobel A., Freitag C.M., Giegling I., et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch. Gen. Psychiatry 2009, 66:41-50.
91. Reif A., Kiive E., Kurrikoff T., Paaver M., Herterich S., Konstabel K., Tulviste T., Lesch K.P., Harro J. A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity. Psychopharmacology (Berl) 2011, 214:239-248.
92. Reijmers L.G., Perkins B.L., Matsuo N., Mayford M. Localization of a stable neural correlate of associative memory. Science 2007, 317:1230-1233.
93. Ribases M., Ramos-Quiroga J.A., Sanchez-Mora C., Bosch R., Richarte V., Palomar G., Gastaminza X., Bielsa A., Arcos-Burgos M., Muenke M., et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes Brain Behav. 2011, 10:149-157.
94. Rivero, O., Sich, S., Popp, S., Schmitt, A., Franke, B., Lesch, K.P. Impact of the ADHD-susceptibility gene CDH13 on the development and function of brain networks. Eur. J. Neuropsychopharmacol., , in press. http://dx.doi.org/10.1016/j.euroneuro.2012.06.009.
95. Romanos M., Freitag C., Jacob C., Craig D.W., Dempfle A., Nguyen T.T., Halperin R., Walitza S., Renner T.J., Seitz C., et al. Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol. Psychiatry 2008, 13:522-530.
96. Romorini S., Piccoli G., Jiang M., Grossano P., Tonna N., Passafaro M., Zhang M., Sala C. A functional role of postsynaptic density-95-guanylate kinase-associated protein complex in regulating Shank assembly and stability to synapses. J. Neurosci. 2004, 24:9391-9404.
97. Rujescu D., Ingason A., Cichon S., Pietilainen O.P., Barnes M.R., Toulopoulou T., Picchioni M., Vassos E., Ettinger U., Bramon E., et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 2009, 18:988-996.
98. Russwurm M., Wittau N., Koesling D. Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J. Biol. Chem. 2001, 276:44647-44652.
99. Sagvolden T., Johansen E.B., Woien G., Walaas S.I., Storm-Mathisen J., Bergersen L.H., Hvalby O., Jensen V., Aase H., Russell V.A., et al. The spontaneously hypertensive rat model of ADHD-the importance of selecting the appropriate reference strain. Neuropharmacology 2009, 57:619-626.
100. Schotanus S.M., Chergui K. Dopamine D1 receptors and group I metabotropic glutamate receptors contribute to the induction of long-term potentiation in the nucleus accumbens. Neuropharmacology 2008, 54:837-844.
101. Schumann G., Johann M., Frank J., Preuss U., Dahmen N., Laucht M., Rietschel M., Rujescu D., Lourdusamy A., Clarke T.K., et al. Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch. Gen. Psychiatry 2008, 65:826-838.
102. Shen W., Flajolet M., Greengard P., Surmeier D.J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 2008, 321:848-851.
103. Silva J.P., Lelianova V., Hopkins C., Volynski K.E., Ushkaryov Y. Functional cross-interaction of the fragments produced by the cleavage of distinct adhesion G-protein-coupled receptors. J. Biol. Chem. 2009, 284:6495-6506.
104. Silva J.P., Lelianova V.G., Ermolyuk Y.S., Vysokov N., Hitchen P.G., Berninghausen O., Rahman M.A., Zangrandi A., Fidalgo S., Tonevitsky A.G., et al. Latrophilin 1 and its endogenous ligand Lasso/teneurin-2 form a high-affinity transsynaptic receptor pair with signaling capabilities. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:12113-12118.
105. Sklar P., Ripke S., Scott L.J., Andreassen O.A., Cichon S., Craddock N., Edenberg H.J., Nurnberger J.I., Rietschel M., Blackwood D., et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 2011, 43:977-983.
106. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:7699-7704.
107. Stergiakouli E., Hamshere M., Holmans P., Langley K., Zaharieva I., Hawi Z., Kent L., Gill M., Williams N., Owen M.J., et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am. J. Psychiatry 2012, 169:186-194.
108. Sudhof T.C. Alpha-latrotoxin and its receptors: neurexins and CIRL/latrophilins. Annu. Rev. Neurosci. 2001, 24:933-962.
109. Sudhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
110. Swanson J., Baler R.D., Volkow N.D. Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2011, 36:207-226.
111. Swanson J.M., Kinsbourne M., Nigg J., Lanphear B., Stefanatos G.A., Volkow N., Taylor E., Casey B.J., Castellanos F.X., Wadhwa P.D. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol. Rev. 2007, 17:39-59.
112. Terauchi A., Johnson-Venkatesh E.M., Toth A.B., Javed D., Sutton M.A., Umemori H. Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature 2010, 465:783-787.
113. Tomasi D., Volkow N.D. Abnormal functional connectivity in children with attention-deficit/hyperactivity disorder. Biol. Psychiatry 2012, 71:443-450.
114. Tu J.C., Xiao B., Naisbitt S., Yuan J.P., Petralia R.S., Brakeman P., Doan A., Aakalu V.K., Lanahan A.A., Sheng M., et al. Coupling of mGluR/homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 1999, 23:583-592.
115. Turic D., Langley K., Mills S., Stephens M., Lawson D., Govan C., Williams N., Van Den Bree M., Craddock N., Kent L., et al. Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-d aspartate glutamate receptor 2A gene polymorphism with ADHD. Mol. Psychiatry 2004, 9:169-173.
116. Turic D., Langley K., Williams H., Norton N., Williams N.M., Moskvina V., Van den Bree M.B., Owen M.J., Thapar A., O'Donovan M.C. A family based study implicates solute carrier family 1-member 3 (SLC1A3) gene in attention-deficit/hyperactivity disorder. Biol. Psychiatry 2005, 57:1461-1466.
117. Tye K.M., Stuber G.D., de Ridder B., Bonci A., Janak P.H. Rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning. Nature 2008, 453:1253-1257.
118. Tye K.M., Tye L.D., Cone J.J., Hekkelman E.F., Janak P.H., Bonci A. Methylphenidate facilitates learning-induced amygdala plasticity. Nat. Neurosci. 2010, 13:475-481.
119. Uhl G.R., Drgon T., Liu Q.R., Johnson C., Walther D., Komiyama T., Harano M., Sekine Y., Inada T., Ozaki N., et al. Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch. Gen. Psychiatry 2008, 65:345-355.
120. Valjent E., Pascoli V., Svenningsson P., Paul S., Enslen H., Corvol J.-C., Stipanovich A., Caboche J., Lombroso P.J., Nairn A.C., et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:491-496.
121. van der Kooij M.A., Glennon J.C. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 2007, 31:597-618.
122. Volkow N.D., Wang G.J., Tomasi D., Kollins S.H., Wigal T.L., Newcorn J.H., Telang F.W., Fowler J.S., Logan J., Wong C.T., et al. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J. Neurosci. 2012, 32:841-849.
123. Voulalas P.J., Holtzclaw L., Wolstenholme J., Russell J.T., Hyman S.E. Metabotropic glutamate receptors and dopamine receptors cooperate to enhance extracellular signal-regulated kinase phosphorylation in striatal neurons. J. Neurosci. Off. J. Soc. Neurosci. 2005, 25:3763-3773.
124. Waider J., Araragi N., Gutknecht L., Lesch K.P. Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: a perspective. Psychoneuroendocrinology 2011, 36:393-405.
125. Wallis D., Hill D.S., Mendez I.A., Abbott L.C., Finnell R.H., Wellman P.J., Setlow B. Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction. Brain Res. 2012, 1463:85-92.
126. Wang L.W., Berry-Kravis E., Hagerman R.J. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 2010, 7:264-274.
127. Weber H., Kittel-Schneider S., Gessner A., Domschke K., Neuner M., Jacob C.P., Buttenschon H.N., Boreatti-Hummer A., Volkert J., Herterich S., et al. Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology 2011, 36:2076-2085.
128. Williams M.E., Wilke S.A., Daggett A., Davis E., Otto S., Ravi D., Ripley B., Bushong E.A., Ellisman M.H., Klein G., et al. Cadherin-9 regulates synapse-specific differentiation in the developing hippocampus. Neuron 2011, 71:640-655.
129. Williams N.M., Franke B., Mick E., Anney R.J., Freitag C.M., Gill M., Thapar A., O'Donovan M.C., Owen M.J., Holmans P., et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am. J. Psychiatry 2012, 169:195-204.
130. Williams N.M., Zaharieva I., Martin A., Langley K., Mantripragada K., Fossdal R., Stefansson H., Stefansson K., Magnusson P., Gudmundsson O.O., et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010, 376:1401-1408.
131. Winstanley C.A., Eagle D.M., Robbins T.W. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin. Psychol. Rev. 2006, 26:379-395.
132. Xiao B., Tu J.C., Worley P.F. Homer: a link between neural activity and glutamate receptor function. Curr. Opin. Neurobiol. 2000, 10:370-374.
133. Xu J., Zhu Y., Contractor A., Heinemann S.F. mGluR5 has a critical role in inhibitory learning. J. Neurosci. Off. J. Soc. Neurosci. 2009, 29:3676-3684.
134. Yamagishi S., Hampel F., Hata K., Del Toro D., Schwark M., Kvachnina E., Bastmeyer M., Yamashita T., Tarabykin V., Klein R., et al. FLRT2 and FLRT3 act as repulsive guidance cues for Unc5-positive neurons. EMBO J. 2011, 30:2920-2933.
135. Zabel U., Kleinschnitz C., Oh P., Nedvetsky P., Smolenski A., Muller H., Kronich P., Kugler P., Walter U., Schnitzer J.E., et al. Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat. Cell Biol. 2002, 4:307-311.
136. Zachariou V., Sgambato-Faure V., Sasaki T., Svenningsson P., Berton O., Fienberg A.A., Nairn A.C., Greengard P., Nestler E.J. Phosphorylation of DARPP-32 at threonine-34 is required for cocaine action. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2006, 31:555-562.
137. Zhang K., Davids E., Tarazi F.I., Baldessarini R.J. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacology (Berl) 2002, 161:100-106.
138. Zhang K., Tarazi F.I., Baldessarini R.J. Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2001, 25:624-632.
139. Zhang Y., Svenningsson P., Picetti R., Schlussman S.D., Nairn A.C., Ho A., Greengard P., Kreek M.J. Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. J. Neurosci. Off. J. Soc. Neurosci. 2006, 26:2645-2651.
140. Zhou K., Dempfle A., Arcos-Burgos M., Bakker S.C., Banaschewski T., Biederman J., Buitelaar J., Castellanos F.X., Doyle A., Ebstein R.P., et al. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B:1392-1398.